Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jan 31, 2024
Open Peer Review Period: Feb 2, 2024 - Mar 29, 2024
Date Accepted: Aug 2, 2024
(closed for review but you can still tweet)
Development and validation of a CT-based model for noninvasive prediction of T stage in gastric cancer: A multicenter study
ABSTRACT
Background:
No studies have reported the use of deep learning radiomics to predict T staging in gastric cancer via integrating radiomics and deep learning.
Objective:
To develop a computed tomography (CT)-based model for the automatic prediction of the T stage of gastric cancer (GC) via radiomics and deep learning.
Methods:
A total of 771 GC patients from 3 centers were retrospectively enrolled and divided into training, validation, and testing cohorts. GC patients were classified into mild (stage T1 and 2), moderate (stage T3) and severe (stage T4) groups. Three predictive models based on the labelled CT images were constructed by using the radiomics features (Radiomics model), deep features (Deep learning model) and the combination of both (Hybrid model).
Results:
The overall classification accuracy of the radiomics model was 64.3% in the internal testing dataset. The deep learning model and hybrid model showed better performance than the radiomics model, with overall classification accuracies of 75.7% (p = 0.037) and 81.4% (p = 0.001), respectively. On the subtasks of binary classification of tumor severity, the AUCs of the radiomics model, deep learning model and hybrid model were 0.875, 0.866 and 0.886 in the internal testing dataset and 0.820, 0.818 and 0.972 in the external testing dataset for differentiating mild (stage T1~2) from nonmild (stage T3~4) patients, while yielding 0.815, 0.892 and 0.894 in the internal testing dataset and 0.685, 0.808 and 0.897 in the external testing dataset for differentiating nonsevere (stage T1~3) from severe (stage T4) patients, respectively.
Conclusions:
The hybrid model integrating radiomics features and deep features shows favorable performance in diagnosing the pathological stage of gastric cancer. Clinical Trial: None
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.